AZN vs SMTK · P/E 28, $288.38B cap vs rev $20.0K
AstraZeneca PLC (AZN) versus SmartKem, Inc. Common Stock (SMTK) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
SmartKem, Inc. Common Stock (SMTK) is a semiconductor equipment & materials company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported SMTK revenue for 2026-06-30 was $20.0K. Net income was -$22.6M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SMTK currently screens at market cap $4.5M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SMTK currently screens at market cap $4.5M.
Not investment advice. Open the AZN and SMTK stock pages for the full models.
Not investment advice.